Skip to content

13F-HR filed by GENERAL ATLANTIC, L.P.

GENERAL ATLANTIC, L.P. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 13 holding rows worth $2,872,723,178.

Accession
0000950142-26-000395
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 13 entries on the cover page, a total value of $2,872,723,178 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,872,723,178 with VALUE read as dollars as filed, 13F file number 028-03473. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DLOCAL LTDG29018101CLASS A COM46,656,695$659,725,667dollars as filed
CHIME FINL INC COM SHS CL A16935C109Stock21,259,683$535,106,221dollars as filed
XP INC CL AG98239109Stock22,699,133$371,584,807dollars as filed
ALKAMI TECHNOLOGY INC01644J108COM11,991,480$276,643,444dollars as filed
ALIGNMENT HEALTHCARE INC COM01625V104Stock13,167,733$260,062,727dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,812,928$224,049,715dollars as filed
PHARVARIS NVN69605108COMMON STOCK8,031,252$222,867,243dollars as filed
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS6,117,715$153,004,052dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK4,897,159$92,899,106dollars as filed
EUROPEAN WAX CTR INC29882P106CLASS A COM13,110,492$47,197,771dollars as filed
RISKIFIED LTD AM8216R109COMMON STOCK5,324,998$26,465,240dollars as filed
GROVE COLLABORATIVE HOLDINGS39957D201Common Stock2,474,859$2,722,345dollars as filed
WEBULL CORPG9572D103ORD SHS50,816$394,840dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950142-26-000395this filing2026-02-17acceptance time not in the bulk data set